Navigation Links
Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
Date:9/15/2009

PALO ALTO, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced that company management will provide a corporate overview at the UBS Global Life Sciences Conference in New York City on Tuesday, September 22, 2009 at 11:30 a.m. Eastern time (8:30 a.m. Pacific time). A live and archived webcast of the presentation will be available on the Telik website, www.telik.com.

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer and inflammatory diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA(R), a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA(R), a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.


'/>"/>
SOURCE Telik, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Telik Reports Positive Results From Phase 1 Dose-Escalation Study of TELINTRA Tablets in Myelodysplastic Syndrome
2. Telik Announces Preclinical Presentations at AACR Annual Meeting
3. Telik Announces Patents on Compounds Related to TELINTRA
4. Telik Announces Year-End Financial Release, Conference Call and Webcast
5. Telik Announces Fourth Quarter and 2008 Year End Financial Results and 2009 Financial Guidance
6. Telik Announces Preclinical Presentations at AACR Annual Meeting
7. Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , ... May 05, 2016 , ... Dr. Benjamin Stong ... non-surgical hair loss treatment. Dr. Stong is double board certified and the only ... for the treatment of hair loss. Non-surgical therapies such as stem cells can be ...
(Date:5/5/2016)... ... , ... Talent Tech Labs (TTL) is pleased to announce its ... Nurses Week (May 6-12). Currently, HireNurses is a job listing and matching platform ... Tech Lab Virtual Incubation program, they will dramatically expand the functionality and ease of ...
(Date:5/5/2016)... ... 05, 2016 , ... VisualDx announced today its ... is the first point of care diagnostic support system to be widely used, ... speeds diagnosis, therapy decisions and patient education for emergency physicians, hospitalists and primary ...
(Date:5/5/2016)... ... May 05, 2016 , ... ACLS Certification ... announce its new referral program, giving participants incentive for spreading the word about ... and we know many professionals share resources with their friends and colleagues,” said ...
(Date:5/5/2016)... ... May 05, 2016 , ... Liposuction specialist Marcia V. Byrd, MD ... Louis, Missouri at the Marriot St. Louis Airport Hotel. This year’s conference was titled ... the conference about her unique specialization in treating Lipedema. Dr. Byrd is considered one ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... PUNE, India , May 4, 2016 /PRNewswire/ ... report spreads across 154 pages, profiling 09 key ... It is a professional and in-depth study on ... providing a basic overview of the industry including ... Insulin Needles market analysis is provided for the ...
(Date:5/3/2016)... 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen ... http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: